Found: 3
Select item for more details and to access through your institution.
Response to Crudele et al. Commentary on Mayock et al. “In Vitro Drug Release after Crushing: Evaluation of Xtampza<sup>®</sup> ER and Other ER Opioid Formulations”.
- Published in:
- Clinical Drug Investigation, 2018, v. 38, n. 8, p. 799, doi. 10.1007/s40261-018-0664-y
- By:
- Publication type:
- Article
Evaluation of an Extended-Release, Abuse-Deterrent, Microsphere-in-Capsule Analgesic for the Management of Patients with Chronic Pain With Dysphagia ( CPD).
- Published in:
- Pain Practice, 2016, v. 16, n. 3, p. 334, doi. 10.1111/papr.12280
- By:
- Publication type:
- Article
Oral Human Abuse Potential of Oxycodone DETERx<sup>®</sup> (Xtampza<sup>®</sup> ER).
- Published in:
- Journal of Clinical Pharmacology, 2017, v. 57, n. 4, p. 500, doi. 10.1002/jcph.833
- By:
- Publication type:
- Article